SWECURE
DEAD

Serial Number

79161776

Owner

Swecure AB

Attorney

Susan M. Natland

Filing Date

Oct 2, 2014

Add to watchlist:

No watchlists yet
View on USPTO

SWECURE Trademark

Serial Number: 79161776 • Registration: 4934502

SWECURE is a trademark filed by Swecure AB on October 2, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Swecure AB

Stureplan 15

Entity Type: 09

Trademark Details

Filing Date

October 2, 2014

Registration Date

April 12, 2016

Published for Opposition

January 26, 2016

Cancellation Date

October 1, 2024

Goods & Services

Dietetic foods adapted for infants, namely, medicinal drinks; Dietetic foods adapted for infants, namely, food supplements; Dietetic foods adapted for infants, namely, liquid-based food and yogurts for medical purposes; Dietetic foods adapted for invalids, namely, medicinal drinks; Dietetic foods adapted for invalids, namely, food supplements; Dietetic foods adapted for invalids, namely, liquid-based food and yogurts for medical purposes; Dietetic foods adapted for medical purposes, namely, medicinal drinks; Dietetic foods adapted for medical purposes, namely, food supplements; Dietetic foods adapted for medical purposes, namely, liquid-based food and yogurts for medical purposes; Medicines for the treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, dental disease, periodontal disease, acute pain, chronic pain, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, Irritable Bowel Syndrome, acute and chronic diarrhea, obesity, asthma, cancer, autoimmune diseases, eczema and psoriasis for human purposes; Pharmaceutical preparations for treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, gastrointestinal conditions, dental disease, periodontal disease, acute pain, chronic pain, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, Irritable Bowel Syndrome, acute and chronic diarrhea, obesity, asthma, cancer, autoimmune diseases, eczema and psoriasis and natural remedies, namely, remedy preparations for treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, gastrointestinal conditions, dental disease, periodontal disease, acute pain, chronic pain, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, Irritable Bowel Syndrome, acute and chronic diarrhea, obesity, asthma, cancer, autoimmune diseases, eczema and psoriasis; Nutritional food additives for medical purposes in the nature of natural food extracts derived from intestinal bacteria for human consumption; Dietetic foods for use in clinical nutrition, namely, medicinal drinks; Dietetic foods for use in clinical nutrition, namely, food supplements; Dietetic foods for use in clinical nutrition, namely, liquid-based food and yogurts for medical purposes; Food for diabetics, namely, medicinal drinks; Food for diabetics, namely, food supplements; Food for diabetics, namely, liquid-based food and yogurts for medical purposes; Food for medically restricted diets, namely, medicinal drinks; Food for medically restricted diets, namely, food supplements; Food for medically restricted diets, namely, liquid-based food and yogurts for medical purposes; Dietary and nutritional supplements for dietetic purposes; dietary and nutritional supplements, namely, tablets, pills, capsules, and liquids for dietetic purposes; Allergy medications; Probiotic bacterial formulations for medical use; Probiotic composition nutritional bacterial formulations for medical use; Bacteriological preparations for medical use; Bacteriological culture mediums for diagnostic purposes; Media for bacteriological cultures; Immunotherapeutic pharmaceutical preparation agents for bacterial infections; Bacterial preparations for medical use

Bacterial cultures for addition to food products; Chemical and biological immunoassay reagents, other than for medical use; Immunoassay diagnostic reagents, other than for medical use, specifically used for science and research; Bacterial substances, namely, preparations for scientific use; Scientific probiotic bacterial formulations, namely, preparations other than for medical use; Diagnostic kits comprised of specimen receptors and reagents for testing for selected bacteria for scientific purposes; Proteins in raw material form for use in science; Proteins for use in the manufacture of foodstuffs; Immunological monoclonal and polyclonal antibodies, other than for medical use, specifically for scientific research; immunological antiserum, other than for medical use, specifically used for scientific research

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 25, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Apr 25, 2025 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Aug 13, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 24, 2023 INTS
INVALIDATION PROCESSED
Jul 24, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 28, 2023 INTR
CANCELLED SECTION 71
Oct 28, 2022 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 12, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 5, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 15, 2016 FICS
FINAL DISPOSITION PROCESSED
Jul 15, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 12, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 12, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 26, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jan 26, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Jan 22, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 6, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 6, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 6, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 16, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 16, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 16, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 16, 2015 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 8, 2015 GNFN
FINAL REFUSAL E-MAILED
Oct 8, 2015 GNFR
FINAL REFUSAL WRITTEN
Oct 8, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 10, 2015 TROA
REFUSAL PROCESSED BY IB
Apr 10, 2015 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2015 RFCS
REFUSAL PROCESSED BY MPU
Mar 23, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 22, 2015 RFCR
NON-FINAL ACTION WRITTEN
Mar 21, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 20, 2015 MAFR
ASSIGNED TO EXAMINER
Mar 16, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2015 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 13, 2015 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 12, 2015 REPR